JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Rabies is one of the deadliest infectious diseases, but it is also preventable when treated quickly after an animal bite. A ...

Rising Cancer Incidence and Technological Innovations Drive Surge in ADC Adoption for Targeted Cancer TherapyAustin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Antibody Drug Conjugates Market Size & Growth ...

When Laura Ehrlich gave birth to her first child in 2020, the COVID-causing virus wasn’t the only threat facing her son. Born ...

Hospitalizations due to RSV cases in infants are reduced by up to 43% following the introduction of new maternal vaccines.

A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong Ye from the University ...

A groundbreaking universal snake antivenom, derived from rare human antibodies, offers hope against deadly bites worldwide.

A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong Ye from the University of Texas San Antonio, has developed a new microfluidic-based biosensing ...

The antibody contract manufacturing market is poised for growth, driven by increasing outsourcing due to cost efficiency and ...

Jade Biosciences (JBIO) unveiled JADE201, its investigational half-life extended, afucosylated monoclonal antibody targeting the B-cell activating ...

This article discusses the advantages of a native anion exchange method coupled to mass spectrometry (MS) for charge ...